These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37209991)

  • 21. Pulsatilla Decoction Combined with 5-Fluorouracil Triggers Immunogenic Cell Death in Colorectal Cancer Cells.
    Jie Y; Yang X; Chen W
    Cancer Biother Radiopharm; 2022 Dec; 37(10):945-954. PubMed ID: 34042519
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapeutic Efficacy of Oxaliplatin and Pembrolizumab Combination Treatment for Triple-Negative Breast Cancer.
    Chu SL
    Stud Health Technol Inform; 2023 Nov; 308():341-350. PubMed ID: 38007758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer.
    Salaroglio IC; Gazzano E; Abdullrahman A; Mungo E; Castella B; Abd-Elrahman GEFA; Massaia M; Donadelli M; Rubinstein M; Riganti C; Kopecka J
    J Exp Clin Cancer Res; 2018 Nov; 37(1):286. PubMed ID: 30482226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restoration of p53 activity via intracellular protein delivery sensitizes triple negative breast cancer to anti-PD-1 immunotherapy.
    Yang Z; Sun JK; Lee MM; Chan MK
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36104100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade.
    Pilones KA; Hensler M; Daviaud C; Kraynak J; Fucikova J; Galluzzi L; Demaria S; Formenti SC
    Oncoimmunology; 2020 Oct; 9(1):1830524. PubMed ID: 33150045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doxorubicin-Loaded Platelet Decoys for Enhanced Chemoimmunotherapy Against Triple-Negative Breast Cancer in Mice Model.
    Dong H; Gao M; Lu L; Gui R; Fu Y
    Int J Nanomedicine; 2023; 18():3577-3593. PubMed ID: 37409026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Everolimus combined with PD-1 blockade inhibits progression of triple-negative breast cancer.
    Li G; Hu J; Cho C; Cui J; Li A; Ren P; Zhou J; Wei W; Zhang T; Liu X; Liu W
    Cell Signal; 2023 Sep; 109():110729. PubMed ID: 37257766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STAT3 and PD-L1 are negatively correlated with ATM and have impact on the prognosis of triple-negative breast cancer patients with low ATM expression.
    Song YM; Qian XL; Xia XQ; Li YQ; Sun YY; Jia YM; Wang J; Xue HQ; Gao GS; Wang XZ; Zhang XM; Guo XJ
    Breast Cancer Res Treat; 2022 Nov; 196(1):45-56. PubMed ID: 36056297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment with eFT-508 increases chemosensitivity in breast cancer cells by modulating the tumor microenvironment.
    Yang ZY; Jiang CW; Zhang WL; Sun G
    J Transl Med; 2022 Jun; 20(1):276. PubMed ID: 35717238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade.
    Qin Y; Vasilatos SN; Chen L; Wu H; Cao Z; Fu Y; Huang M; Vlad AM; Lu B; Oesterreich S; Davidson NE; Huang Y
    Oncogene; 2019 Jan; 38(3):390-405. PubMed ID: 30111819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Many faces of DAMPs in cancer therapy.
    Krysko O; Løve Aaes T; Bachert C; Vandenabeele P; Krysko DV
    Cell Death Dis; 2013 May; 4(5):e631. PubMed ID: 23681226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition.
    Raninga PV; Lee A; Sinha D; Dong LF; Datta KK; Lu X; Kalita-de Croft P; Dutt M; Hill M; Pouliot N; Gowda H; Kalimutho M; Neuzil J; Khanna KK
    Theranostics; 2020; 10(12):5259-5275. PubMed ID: 32373211
    [No Abstract]   [Full Text] [Related]  

  • 33. Walking Dead Tumor Cells for Targeted Drug Delivery Against Lung Metastasis of Triple-Negative Breast Cancer.
    Zhao Z; Fang L; Xiao P; Sun X; Zhou L; Liu X; Wang J; Wang G; Cao H; Zhang P; Jiang Y; Wang D; Li Y
    Adv Mater; 2022 Aug; 34(33):e2205462. PubMed ID: 35759925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of three commercial photosensitizers for efficiency of inducing immunogenic cell death in anti-tumor immunotherapy].
    Lin X; Mao D; Bai R
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1791-1798. PubMed ID: 36651246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-TGF-β/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer.
    Yi M; Wu Y; Niu M; Zhu S; Zhang J; Yan Y; Zhou P; Dai Z; Wu K
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36460337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An ER-Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non-Small-Cell Lung Cancer.
    Wang L; Guan R; Xie L; Liao X; Xiong K; Rees TW; Chen Y; Ji L; Chao H
    Angew Chem Int Ed Engl; 2021 Feb; 60(9):4657-4665. PubMed ID: 33217194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death.
    Hodge JW; Garnett CT; Farsaci B; Palena C; Tsang KY; Ferrone S; Gameiro SR
    Int J Cancer; 2013 Aug; 133(3):624-36. PubMed ID: 23364915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenic cell death due to a new photodynamic therapy (PDT) with glycoconjugated chlorin (G-chlorin).
    Tanaka M; Kataoka H; Yano S; Sawada T; Akashi H; Inoue M; Suzuki S; Inagaki Y; Hayashi N; Nishie H; Shimura T; Mizoshita T; Mori Y; Kubota E; Tanida S; Takahashi S; Joh T
    Oncotarget; 2016 Jul; 7(30):47242-47251. PubMed ID: 27363018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis.
    Zhu H; Yang K; Yao H; Chen X; Yan S; He Y; Cao Y; Luo J; Wang D
    Int J Nanomedicine; 2023; 18():3109-3124. PubMed ID: 37323948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nano-Pulse Stimulation is a physical modality that can trigger immunogenic tumor cell death.
    Nuccitelli R; McDaniel A; Anand S; Cha J; Mallon Z; Berridge JC; Uecker D
    J Immunother Cancer; 2017; 5():32. PubMed ID: 28428881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.